Adjuvant Therapy for Diabetes Mellitus-2

Mechanistic Investigation of TABATA Training as an Adjuvant Therapy in Type-2 Diabetes Management

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063063

Enrollment

165

Registered

2024-02-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Tabata Training: Total sets/day: 8 comprehensive sets Frequency of exercise: 4 times in a week Mode of Exercise: Tabata Training Ratio: 20:10 seconds Intervention: 20-s extreme focus

Eligibility

Inclusion criteria

Inclusion criteria: Early diagnosed Type 2 diabetes Age 30-40 Males BMI 20-25 diet or tablet treatment for diabetes

Exclusion criteria

Exclusion criteria: Joint (Lower limb) pathologies diseases other than type 2 diabetes (e.g. Cardiac issues, Hyperlipidemia, Metabolic disorders) insulin treatment Females Age >40

Design outcomes

Primary

Measure	Time frame
To uncover and understand the physiological and molecular mechanisms by which Tabata Training impacts individuals with Type-2 diabetesTimepoint: 1. at the starting of study 2. after 6 months of intervention	—

Secondary

Measure	Time frame
NILTimepoint: NA	—

Countries

India

Contacts

Public ContactRituraj Verma

Sharda University

sandeep.shukla@sharda.ac.in9805205920

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026